Lördag 12 September | 16:43:02 Europe / Stockholm
Est. tid*
2027-02-11 08:10 Bokslutskommuniké 2026
2026-08-20 - Kvartalsrapport 2026-Q2
2026-03-24 - X-dag halvårsutdelning NSIS B 2
2026-03-23 - Årsstämma
2026-02-25 - Bokslutskommuniké 2025
2025-08-25 - X-dag halvårsutdelning NSIS B 2.25
2025-08-21 - Kvartalsrapport 2025-Q2
2025-04-04 - X-dag halvårsutdelning NSIS B 2.1
2025-04-03 - Årsstämma
2025-02-26 - Bokslutskommuniké 2024
2024-08-30 - X-dag halvårsutdelning NSIS B 2
2024-08-28 - Kvartalsrapport 2024-Q2
2024-05-01 - X-dag halvårsutdelning NSIS B 2
2024-04-30 - Årsstämma
2024-03-04 - Extra Bolagsstämma 2024
2024-02-08 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-10-13 - X-dag bonusutdelning NSIS B 4.2
2023-08-09 - Kvartalsrapport 2023-Q2
2023-04-26 - Kvartalsrapport 2023-Q1
2023-03-30 - Extra Bolagsstämma 2023
2023-03-03 - X-dag ordinarie utdelning NSIS B 6.00 DKK
2023-03-02 - Årsstämma
2023-01-26 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-11 - Kvartalsrapport 2022-Q2
2022-04-27 - Kvartalsrapport 2022-Q1
2022-03-17 - X-dag ordinarie utdelning NSIS B 5.50 DKK
2022-03-16 - Årsstämma
2022-02-01 - Bokslutskommuniké 2021
2021-10-27 - Kvartalsrapport 2021-Q3
2021-08-12 - Kvartalsrapport 2021-Q2
2021-04-27 - Kvartalsrapport 2021-Q1
2021-03-12 - X-dag ordinarie utdelning NSIS B 5.25 DKK
2021-03-11 - Årsstämma
2021-02-02 - Bokslutskommuniké 2020
2020-10-21 - Kvartalsrapport 2020-Q3
2020-08-12 - Kvartalsrapport 2020-Q2
2020-04-29 - Kvartalsrapport 2020-Q1
2020-02-27 - X-dag ordinarie utdelning NSIS B 5.25 DKK
2020-02-26 - Årsstämma
2020-01-23 - Bokslutskommuniké 2019
2019-10-23 - Kvartalsrapport 2019-Q3
2019-08-08 - Kvartalsrapport 2019-Q2
2019-04-24 - Kvartalsrapport 2019-Q1
2019-02-28 - X-dag ordinarie utdelning NSIS B 5.00 DKK
2019-02-27 - Årsstämma
2019-01-24 - Bokslutskommuniké 2018
2018-10-24 - Kvartalsrapport 2018-Q3
2018-08-10 - Kvartalsrapport 2018-Q2
2018-04-25 - Kvartalsrapport 2018-Q1
2018-03-14 - X-dag ordinarie utdelning NSIS B 4.50 DKK
2018-03-13 - Årsstämma
2018-02-07 - Bokslutskommuniké 2017
2017-10-25 - Kvartalsrapport 2017-Q3
2017-08-11 - Kvartalsrapport 2017-Q2
2017-04-26 - Kvartalsrapport 2017-Q1
2017-02-23 - X-dag ordinarie utdelning NSIS B 4.00 DKK
2017-02-22 - Årsstämma
2017-01-18 - Bokslutskommuniké 2016
2016-10-26 - Kvartalsrapport 2016-Q3
2016-08-10 - Kvartalsrapport 2016-Q2
2016-04-20 - Kvartalsrapport 2016-Q1
2016-02-25 - X-dag ordinarie utdelning NSIS B 3.50 DKK
2016-02-24 - Årsstämma
2016-01-19 - Bokslutskommuniké 2015
2015-10-22 - Kvartalsrapport 2015-Q3
2015-08-06 - Kvartalsrapport 2015-Q2
2015-04-23 - Kvartalsrapport 2015-Q1
2015-02-26 - X-dag ordinarie utdelning NSIS B 3.00 DKK
2015-02-25 - Årsstämma
2015-01-20 - Bokslutskommuniké 2014
2014-10-23 - Kvartalsrapport 2014-Q3
2014-08-14 - Kvartalsrapport 2014-Q2
2014-04-24 - Kvartalsrapport 2014-Q1
2014-02-27 - X-dag ordinarie utdelning NSIS B 2.50 DKK
2014-02-26 - Årsstämma
2014-01-21 - Bokslutskommuniké 2013
2013-10-25 - Kvartalsrapport 2013-Q3
2013-08-09 - Kvartalsrapport 2013-Q2
2013-04-25 - Kvartalsrapport 2013-Q1
2013-03-01 - X-dag ordinarie utdelning NSIS B 2.20 DKK
2013-02-28 - Årsstämma
2012-10-25 - Kvartalsrapport 2012-Q3
2012-08-16 - Kvartalsrapport 2012-Q2
2012-04-25 - Kvartalsrapport 2012-Q1
2012-03-01 - X-dag ordinarie utdelning NSIS B 1.90 DKK
2012-02-29 - Årsstämma
2012-01-19 - Bokslutskommuniké 2011
2011-11-28 - Split NSIS B 1:5
2011-10-28 - Kvartalsrapport 2011-Q3
2011-08-11 - Kvartalsrapport 2011-Q2
2011-04-29 - Kvartalsrapport 2011-Q1
2011-03-03 - X-dag ordinarie utdelning NSIS B 8.00 DKK
2011-03-02 - Årsstämma
2011-01-21 - Bokslutskommuniké 2010
2010-10-28 - Kvartalsrapport 2010-Q3
2010-08-12 - Kvartalsrapport 2010-Q2
2010-04-29 - Kvartalsrapport 2010-Q1
2010-03-04 - X-dag ordinarie utdelning NSIS B 5.75 DKK
2010-03-03 - Årsstämma
2009-03-05 - X-dag ordinarie utdelning NSIS B 5.25 DKK
2008-03-06 - X-dag ordinarie utdelning NSIS B 5.00 DKK
2007-03-09 - X-dag ordinarie utdelning NSIS B 4.50 DKK
2006-03-02 - X-dag ordinarie utdelning NSIS B 4.00 DKK
2005-03-17 - X-dag ordinarie utdelning NSIS B 3.50 DKK
2004-03-18 - X-dag ordinarie utdelning NSIS B 3.15 DKK
2003-03-20 - X-dag ordinarie utdelning NSIS B 2.25 DKK
2002-03-21 - X-dag ordinarie utdelning NSIS B 2.00 DKK
2001-03-22 - X-dag ordinarie utdelning NSIS B 1.65 DKK
LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriBioteknik
Novonesis är verksamma inom biokemi. Bolaget utvecklar enzymer och mikroorganismer för industriellt bruk. Enzymerna är ett protein som används inom ett flertal olika branscher, huvudsakligen inom jordbruks- och livsmedelsindustrin. Produkterna används inom livsmedel samt kläder, och försäljning innehas på global nivå, med störst närvaro inom Norden och Europa. Bolaget har sitt huvudkontor i Bagsværd.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent

2026-08-26 14:00:00

Blair, Nebraska, Aug. 26, 2026 (GLOBE NEWSWIRE) -- As the U.S. biotechnology sector grows, developing the skilled workforce needed to turn scientific innovation into products at commercial scale is becoming increasingly important. Novonesis, a global leader in biosolutions, is expanding its U.S. workforce development efforts through partnerships that connect students with biotechnology education, hands-on learning and pathways to careers in biomanufacturing. 

The latest example is in Nebraska, where Novonesis is partnering with Metropolitan Community College (MCC) in Omaha to help shape the college’s new biotechnology technician training program and is announcing the Novonesis Biomanufacturing Pathways Scholarship to help remove financial barriers for students pursuing careers in the industry. The partnership comes as Nebraska bioscience employment grew 6.3% from 2019 to 2023, compared with 2.9% growth across the state’s overall private sector. 

“Building the future of biotechnology requires investing in people as well as science and technology,” said Tue Micheelsen, President of Novonesis North America. “Across the country, we’re working with educators and communities to help more people see what modern biomanufacturing looks like, develop the skills our industry needs and discover meaningful careers they may never have considered. These partnerships strengthen our workforce while helping the U.S. continue to lead in biotechnology.”

Connecting education with real-world careers

Biomanufacturing uses biological processes to make products at commercial scale, requiring skilled employees to operate equipment, monitor production processes and help ensure products are made safely and consistently. Production roles are critical to Novonesis’ ability to manufacture biosolutions used across industries ranging from agriculture and renewable energy to food, health and household care. Novonesis has a significant manufacturing footprint across the U.S., including North America’s largest multipurpose enzyme manufacturing site in Franklinton, North Carolina; the nation’s largest enzyme production site dedicated to biofuels in Blair, Nebraska; North America’s largest liquid inoculants manufacturing site in Milwaukee; and its largest food cultures manufacturing site in West Allis, Wisconsin. Recruiting skilled people for production roles across this network is critical to supporting Novonesis’ continued growth. 

Recognizing that workforce challenges can’t be solved through hiring alone, Novonesis partners with educational institutions, workforce development organizations and community groups to build long-term talent pipelines in the regions where it operates.

In Nebraska, that approach is taking shape through Novonesis’ partnership with MCC. Company employees joined MCC’s Business & Industry Leadership Team (BILT) to help shape a biotechnology program that reflects the skills employers need. The program includes a 15-week Biotechnology Fundamentals Microcredential providing a rapid-entry workforce option and a Biotechnology Career Certificate creating a pathway to continued education and careers in the field. Beginning this fall, students will complement classroom learning with production job shadowing and facility tours at Novonesis’ Blair manufacturing site and Employer Spotlight sessions on campus. Students completing the micro credential will also have an opportunity to be screened by a Novonesis recruiter. 

The new Novonesis Biomanufacturing Pathways Scholarship adds another piece to that pathway, with an endowed fund to provide ongoing support for future students. The scholarship will help make biotechnology education more accessible while connecting financial support with industry-informed curriculum and real-world learning experiences.

“The strongest workforce programs are built with employers at the table from the beginning,” said Neil Riley, Associate Dean of Math and Natural Sciences at MCC. “Novonesis has been an invaluable partner, helping shape this program based on the skills biotechnology companies need today and tomorrow. Students graduate with technical knowledge, real-world experience, professional connections, and opportunities for financial assistance that can help them launch successful careers.” 

Building the talent pipeline across the U.S.

The Nebraska partnership is part of a broader Novonesis approach to building biotechnology talent by engaging students at multiple points in their education and career journeys.

Engagement with K-12 students through field trips and in-class visits helps introduce younger generations to STEM and modern manufacturing before they begin making decisions about college, training and careers. Each October, Novonesis participates in Manufacturing Day, an initiative of The Manufacturing Institute, welcoming high school students to tour research laboratories and production facilities, interact with engineers and operators, and explore how biology is helping solve challenges related to food, fuel, health, and sustainability. Following Novonesis’ 2025 Manufacturing Day flagship event in Franklinton, 93% of participating students said the experience introduced them to career pathways they had not previously considered.

Community college partnerships are also a vital component of the company’s talent acquisition approach. In North Carolina, Novonesis helped establish the BioWork program more than two decades ago alongside the North Carolina Biotechnology Center and community colleges, creating a certificate pathway into process technician careers. 

At the university and research level, Novonesis also collaborates with academic institutions to advance biotechnology innovation and capabilities. The company works with North Carolina State University and engages students through classroom outreach, site visits, scholarships, internships and other initiatives. In Davis, California, a U.S. National Science Foundation-funded collaboration brings together experts from Novonesis, Stanford University and the University of California, Davis to advance AI-enabled protein design and cell-free biomanufacturing. The collaboration demonstrates another role industry-academic partnerships can play in developing scientific capabilities and advancing U.S. biotechnology leadership. 

Together, these efforts, combined with internships and other programs across the company’s 14 North American sites, reflect a workforce strategy that begins well before a job application with a goal of building awareness among younger students, creating accessible pathways into technical careers and connecting higher education and research with real-world biotechnology challenges.

As Novonesis continues to grow its U.S. operations and capabilities, developing a skilled biotechnology workforce will be critical not only to the company’s growth, but to the country’s ability to scale biomanufacturing and maintain its leadership in biotechnology.

About Novonesis
Novonesis is a global biosolutions company leading the era of biosolutions. By leveraging the power of microbiology with science, Novonesis transforms the way the world produces, consumes, and lives. Across more than 30 industries, Novonesis biosolutions are already creating value for thousands of customers while benefiting the planet. With more than 11,000 employees worldwide, Novonesis partners with businesses and communities to better our world with biology.